150
Participants
Start Date
February 2, 2024
Primary Completion Date
May 30, 2026
Study Completion Date
June 30, 2026
AON-D21
AON-D21 is a Pegylated L-configured aptamer that binds and thereby neutralizes the complement component C5a from activating both C5a receptors.
Placebo
Sterile liquid formulation of 5% glucose solution in matched glass vials with a 1.5 mL fill volume.
RECRUITING
Cliniques Universitaires Saint-Luc, Brussels
RECRUITING
Clinique Saint Pierre, Ottignies
RECRUITING
Centre Hospitalier Argenteuil, Argenteuil
RECRUITING
Centre Hospitalier Départemental Vendée, La Roche-sur-Yon
RECRUITING
CHU Dupuytren, Limoges
RECRUITING
Centre Hospitalier de Melun, Melun
RECRUITING
Hotel Dieu - CHU Nantes, Nantes
RECRUITING
Assistance Publique-Hopitaux de Paris (AP-HP), Paris
RECRUITING
Nouvel Hôpital Civil, Strasbourg
RECRUITING
CHRU de Tours Hôpital Bretonneau, Tours
RECRUITING
Hôpital Nord Franche Comté, Trévenans
RECRUITING
Charité - Universitätsmedizin Berlin, Berlin
RECRUITING
Cologne-Merheim Hospital Lung Clinic, Cologne
RECRUITING
University Hospital Cologne, Cologne
RECRUITING
Universitaetsklinikum Giessen und Marburg GmbH, Giessen
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
RECRUITING
Hospital Doctor Josep Trueta, Girona
RECRUITING
Hospital Clinico San Carlos, Madrid
RECRUITING
Hospital Universitari Mútua Terrassa, Terrassa
RECRUITING
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
RECRUITING
University Hospital Bristol and Weston NHS, Bristol
RECRUITING
University Hospital of Wales, Cardiff
RECRUITING
Liverpool University Hospitals NHS Foundation Trust, Liverpool
RECRUITING
University College London, London
RECRUITING
University Hospitals Plymouth NHS Trust, Derriford Hospital, Plymouth
RECRUITING
Royal Berkshire Foundation Trust, Reading
RECRUITING
Mid Yokshire Teaching NHS Trust, Wakefield
RECRUITING
York Hospital, York
Lead Sponsor
Aptarion Biotech AG
INDUSTRY